HP
33
3
HAS
64
4
PPL
59
4
L
52
2
VNO
46
-5
FIS
55
9
NDAQ
70
3
PCAR
30
-4
ORLY
52
-9
AN
43
-6
EXPD
29
2
VFC
48
5
GRMN
49
3
CRM
45
3
MO
39
-3
DOW
35
-9
GE
71
-6
FTI
56
-5
MSI
58
3
HAL
50
4
HP
33
3
HAS
64
4
PPL
59
4
L
52
2
VNO
46
-5
FIS
55
9
NDAQ
70
3
PCAR
30
-4
ORLY
52
-9
AN
43
-6
EXPD
29
2
VFC
48
5
GRMN
49
3
CRM
45
3
MO
39
-3
DOW
35
-9
GE
71
-6
FTI
56
-5
MSI
58
3
HAL
50
4
Financhill
Back

Candel Therapeutics Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
64

CADL
Candel Therapeutics

Last Price:
$6.76
Seasonality Move:
-18.58%

7 Day Trial

ALL ACCESS PASS

$ 7

Candel Therapeutics Stock Forecast

  • Over the next 52 weeks, Candel Therapeutics has on average historically risen by 133.2% based on the past 3 years of stock performance.
  • Candel Therapeutics has risen higher in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
  • Is Candel Therapeutics Stock Undervalued?
    The current Candel Therapeutics [CADL] share price is $6.92. The Score for CADL is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • CADL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Candel Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Candel Therapeutics has on average historically risen by 133.2% based on the past 3 years of stock performance.

Candel Therapeutics Stock Rating

Buy
64
Candel Therapeutics (CADL) is a Buy

Is Candel Therapeutics overpriced?

  • Candel Therapeutics has risen higher in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%

Candel Therapeutics Stock Price History

Is CADL stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CADL is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
candeltx.com

52-Week Data

52-Week High:
14.60
52-Week Low:
3.79

Prediction Charts

Market Cap:
346.7M
Price in USD:
6.92
Volume:
1.3M
Beta:
-0.93

Technical Analysis

SMA50:
5.41
SMA100:
6.01
SMA200:
6.36
52-Wk Change:
5.33%

Stock Predictions

  • Is Candel Therapeutics stock public?
    Yes, Candel Therapeutics is a publicly traded company.
  • What is the Candel Therapeutics stock quote today?
    The Candel Therapeutics stock price is 6.92 USD today.
  • How to buy Candel Therapeutics stock online?
    You can buy Candel Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-27 5.01 4.90 5.11 4.85
Jun-30 5.04 5.06 5.24 4.88
Jul-1 4.95 4.85 4.96 4.73
Jul-2 4.86 4.99 5.07 4.85
Jul-3 4.95 5.10 5.12 4.89
Jul-7 5.06 4.99 5.10 4.86
Jul-8 5.03 5.24 5.28 5.00
Jul-9 5.34 6.09 6.24 5.33
Jul-10 6.20 6.15 6.42 5.85
Jul-11 6.09 5.81 6.12 5.78
Jul-14 5.96 6.43 6.45 5.83
Jul-15 6.50 6.25 6.66 6.15
Jul-16 6.33 6.85 6.89 6.33
Jul-17 6.96 6.92 7.25 6.81

Candel Therapeutics Earnings

Candel Therapeutics Earnings Report: Per Share Candel Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Candel Therapeutics Forecast Revenue Growth

Candel Therapeutics Stock Analysis: Historical quarterly revenues per share for Candel Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.03 per share.

* Candel Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.